// App-Quantinova.ai

: The NSD2 p.E1099K Mutation in Relapse Pediatric Acute Lymphoblastic Leukemia Is Linked to Mercaptopurine Resistance

Researchers

Presenter

  • Jason Saliba

Principal Investigators

  • Joanna Pierro

  • Nikki Ann Evensen

  • Anita Qualls

  • Natasha Belsky

  • William L. Carroll

Medical Centers

  • Perlmutter Cancer Center at NYU Langone Health, New York University, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Allmercap

  • Methotrexate

  • Doxorubicin

  • Cytarabine liposomal

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved